Literature DB >> 23436132

Outcome prediction in intracranial tumor surgery: the National Surgical Quality Improvement Program 2005-2010.

Kimon Bekelis1, Samuel F Bakhoum, Atman Desai, Todd A Mackenzie, David W Roberts.   

Abstract

Accurate knowledge of individualized risks is crucial for decision-making in the surgical management of patients with brain tumors. Precise delineation of those risks remains a topic of debate. We attempted to create a predictive model of outcomes in patients undergoing craniotomies for tumor resection (CTR). We performed a retrospective cohort study involving patients who underwent CTR from 2005 to 2010 and were registered in the American College of Surgeons National Quality Improvement Project database. A model for outcome prediction based on individual patient characteristics was developed. Of the 1,834 patients, 457 had meningiomas (24.9 %) and 1377 had non-meningioma tumors (75.1 %). The respective 30-day postoperative risks were 2.1 % for stroke, 1.3 % for MI, 2.7 % for death, 2.4 % for deep surgical site infection, and 6.6 % for return to the OR. Multivariate analysis demonstrated that pre-operative tumor-related neurologic deficit, stroke, altered mental status, and weight loss, were independently associated with most outcomes, including post-operative MI, death, and deep surgical site infection. An additive effect of the variables on the risk of all outcomes was observed. A validated model for outcome prediction based on individual patient characteristics was developed. The accuracy of the model was estimated by the area under the receiver operating characteristic curve, which was 0.687, 0.929, 0.749, 0.746, and 0.679 for postoperative risk of stroke, MI, death, infection, and return to the OR, respectively. Our model can provide individualized estimates of the risks of post-operative complications based on pre-operative conditions, and can potentially be utilized as an adjunct in the decision-making for surgical intervention in brain tumor patients.

Entities:  

Mesh:

Year:  2013        PMID: 23436132      PMCID: PMC5617728          DOI: 10.1007/s11060-013-1089-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  26 in total

1.  Complications of first craniotomy for intra-axial brain tumour.

Authors:  A M Cabantog; M Bernstein
Journal:  Can J Neurol Sci       Date:  1994-08       Impact factor: 2.104

2.  Awake craniotomy for removal of intracranial tumor: considerations for early discharge.

Authors:  H J Blanshard; F Chung; P H Manninen; M D Taylor; M Bernstein
Journal:  Anesth Analg       Date:  2001-01       Impact factor: 5.108

3.  A proposed preoperative grading scheme to assess risk for surgical resection of primary and secondary intraaxial supratentorial brain tumors.

Authors:  S J Vorster; G H Barnett
Journal:  Neurosurg Focus       Date:  1998-06-15       Impact factor: 4.047

4.  Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.

Authors:  Fred G Barker; William T Curry; Bob S Carter
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

5.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

Authors:  B C Devaux; J R O'Fallon; P J Kelly
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

6.  Morbidity and mortality of craniotomy for excision of supratentorial gliomas.

Authors:  C Fadul; J Wood; H Thaler; J Galicich; R H Patterson; J B Posner
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

7.  Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.

Authors:  F W Kreth; P C Warnke; R Scheremet; C B Ostertag
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

8.  Craniotomy for resection of meningioma in the elderly: a multicentre, prospective analysis from the National Surgical Quality Improvement Program.

Authors:  Chirag G Patil; Anand Veeravagu; Shivanand P Lad; Maxwell Boakye
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-13       Impact factor: 10.154

9.  Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care.

Authors:  W A Taylor; N W Thomas; J A Wellings; B A Bell
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

10.  Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload.

Authors:  Fred G Barker
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  5 in total

1.  Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma.

Authors:  Jeff S Ehresman; Tomas Garzon-Muvdi; Davis Rogers; Michael Lim; Gary L Gallia; Jon Weingart; Henry Brem; Chetan Bettegowda; Kaisorn L Chaichana
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-17

2.  Regional disparities in hospitalization charges for patients undergoing craniotomy for tumor resection in New York State: correlation with outcomes.

Authors:  Symeon Missios; Kimon Bekelis
Journal:  J Neurooncol       Date:  2016-04-12       Impact factor: 4.130

3.  Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.

Authors:  Nikita Lakomkin; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2017-12-05       Impact factor: 4.130

4.  Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Authors:  Aditya V Karhade; Luis Fandino; Saksham Gupta; David J Cote; Julian B Iorgulescu; Marike L Broekman; Linda S Aglio; Ian F Dunn; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

5.  Time course of neurological deficits after surgery for primary brain tumours.

Authors:  Maria Zetterling; Kristin Elf; Robert Semnic; Francesco Latini; Elisabeth Ronne Engström
Journal:  Acta Neurochir (Wien)       Date:  2020-07-02       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.